Stockholders' Equity (Tables)

3 Months Ended

Mar. 31, 2023

Schedule of basic and diluted per share results

	For the Three Months Ended
	March 31, 2023		March 31, 2022
Net (loss) income	$	(5,777)	$	269
Weighted average shares outstanding for computation of basic per share results		10,194		10,185
Incremental shares from assumed exercise of stock options and warrants and the grant of restricted stock units (a)		—		236
Adjusted weighted average shares for computation of diluted per share results		10,194		10,421

(a) Incremental shares from the assumed exercise of INDUS stock options are not included in periods where the inclusion of such shares would be anti-dilutive. The incremental shares from the assumed exercise of stock options and warrants and the grant of restricted stock units for the three months ended March 31, 2023 would have been 167.

Schedule of unrecognized compensation expense related to nonvested stock options

Balance of 2023	$	154
2024	$	111
2025	$	15

Schedule of option holders

Schedule of options by range of exercise prices

				Weighted Avg.
				Remaining
Range of Exercise Prices for	Outstanding at	Weighted Avg.		Contractual Life	Total Intrinsic
Outstanding Options	March 31, 2023	Exercise Price		(in years)	Value
$23.00 - $28.00	74,663	$	26.29	3.0	$	2,987
$28.00 - $32.00	14,073	$	29.84	2.3		513
$32.00 - $47.00	122,966	$	44.13	6.8		2,725
	211,702	$	36.89	5.2	$	6,225
Vested options	143,561	$	32.82	4.4	$	4,805

Summary of company's common dividends

For the three months ended March 31, 2023, the Company’s common dividend was as follows:

Quarter Ended	Record Date	Payment Date	Common dividend per share
March 31, 2023	March 31, 2023	April 14, 2023	$0.18

For the three months ended March 31, 2022, the Company’s common dividend was as follows:

Quarter Ended	Record Date	Payment Date	Common dividend per share
March 31, 2022	March 31, 2022	April 15, 2022	$0.16

Restricted Stock Units (RSUs)

Schedule of unrecognized compensation expense related to nonvested stock options

Balance of 2023	$	1,084
2024	$	852
2025	$	418
2026	$	29

Schedule of compensation expense and related tax benefits for stock options

	For the Three Months Ended
	March 31, 2023		March 31, 2022
Compensation expense	$	503	$	273

Time Based Restricted Stock Units

Summary of activity for restricted stock units

	Time-based vesting
	March 31, 2023			March 31, 2022
	Number of		Grant Date Fair	Number of		Grant Date Fair
	Units		Value Weighted Avg.	Units		Value Weighted Avg.
Outstanding at beginning of period	22,332	$	66.56	12,829	$	64.43
Granted	11,692	$	63.82	7,991	$	76.71
Adjustment for dividends	63	$	—	26	$	—
Vested and distributed	(3,294)	$	67.09	(2,718)	$	63.15
Forfeited	—	$	—	(813)	$	63.15
Outstanding at end of period	30,793	$	65.33	17,315	$	70.26

Performance Shares

Summary of activity for restricted stock units